Human Genome Sciences Inc's ROA from the second quarter of 2012 to the second quarter of 2011 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Human Genome Sciences Inc's ROA in the second quarter of 2012?
Human Genome Sciences Inc recorded a cumulative net loss of $-356 million during 12 months ending in the second quarter of 2012, resulting in a negative return on assets (ROA) of -26.73%.

However, within the Healthcare sector 137 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2012 from 1336 to 2294.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter	(Jun 30 2011) II. Quarter
Y / Y Total Assets Change	-14.08 %	39.51 %	-17.3 %	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-356	-344	-381	-388	-340
Return On Assets (TTM)	-26.73 %	-24.84 %	-29.74 %	-28.46 %	-31.1 %
HGSI's Total Ranking	# 2294	# 1336	# 1297	#	#
Total Assets (TTM) in million	1,275	1,434	1,541	1,073	1,484
Seq. Total Assets Change	-11.06 %	-6.93 %	43.61 %	-27.72 %	44.4 %
Seq. Net Income Change	-	-	-	-	-

HGSI's 5 Years Annual ROA >> Back to HGSI Management Effectiveness >> Compare HGSI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 7
Sector	# 138
Overall	# 1883

Return On Assets Statistics
High	Average	Low
-27.59 %	-28.96 %	-31.44 %
(Mar 31 2012)		(Dec 31 2011)

Financial Statements
Human Genome Sciences Inc's Assets	$ 1,275 million	HGSI's Balance sheet
Human Genome Sciences Inc's Income	$ -93 million	Quarterly HGSI's Income Statement
HGSI's Income by Division		See HGSI's Income by Division

Annual Return On Assets	(Dec 31 2009) FY 2011	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	1,863	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	6	0	0	0	0
Annual Return On Assets	0.3 %	-	-	-	-

HGSI's 5 Years Annual ROA >> Back to HGSI Management Effectiveness >> Compare HGSI ROA to its Competitors

Comment on HGSI's ROA in the fiscal year ending 2011

In the fiscal year 2011 ROA improved to 0.3 % compared to prior year, due to annual net income growth of % to $5.66 million, while value of Human Genome Sciences Inc's overall assets grew just by % to $1,863.14 million, compared to $1,863.14 a year before.

More Return On Assets Ratios
HGSI's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HGSI's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HGSI's Competitors
Subscribers only: Roa for Human Genome Sciences Inc's Suppliers
Subscribers only: Return On Assets for HGSI's Customers

You may also want to know
HGSI's Roi	HGSI's Inventory Turnover Ratio	HGSI's Growth Rates	HGSI's Dividend Comparisons
	HGSI's Profitability Ratios	HGSI's Asset Turnover Ratio	HGSI's Dividend Growth
HGSI's Roe	HGSI's Valuation Ratios	HGSI's Financial Strength Ratios	HGSI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2012, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:07:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.